NVIDIA DGX A100 contains a vulnerability in SBIOS in the BiosCfgTool, where a local user with elevated privileges can read and write beyond…

published 2022-07-02 4y ago modified 2026-06-17 4mo ago also EUVD-2022-32654

cvss: 8.2; version 3.1, CNA
cisa kev: Not listed; not in CISA's catalog
epss: 0.2%; EPSS 0.2% chance of exploitation in 30 days, percentile 16%
public exploits: 0; none known

NVIDIA DGX A100 contains a vulnerability in SBIOS in the BiosCfgTool, where a local user with elevated privileges can read and write beyond intended bounds in SMRAM, which may lead to code execution, escalation of privileges, denial of service, and information disclosure. The scope of impact can extend to other components.

Patch / fix

fixed in 1

nvidia dgx_a100_firmware 22.5.5

Is CVE-2022-28200 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.

Check with Fencer

Exploit prediction

0.25% chance of exploitation in the next 30 days, higher than 16% of all scored CVEs (FIRST EPSS, 2026-11-09).

CVSS scores

assigned by	version	score	vector
CNA	3.1	8.2	CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H
NVD	3.1	8.2	CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H
NVD	2.0	4.6	AV:L/AC:L/Au:N/C:P/I:P/A:P

Affected products

NVIDIA NVIDIA DGX A100

Classification

Weakness

CWE-119 Improper Restriction of Operations within the Bounds of a Memory Buffer
CWE-787 Out-of-bounds Write

References

nvidia.custhelp.com /app/answers/detail/a_id/5367
vendor-advisory

Sources

CVE List CVE-2022-28200
NVD CVE-2022-28200

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.